Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
暂无分享,去创建一个
Timothy R. Walsh | Mark A. Toleman | Kyungwon Lee | Dongeun Yong | Hyun-soo Cho | M. Toleman | D. Yong | T. Walsh | C. Giske | Kyungwon Lee | K. Sundman | Christian G. Giske | Hyun S. Cho | Kristina Sundman
[1] M. Botta,et al. Crystal structure of the OXA-48 beta-lactamase reveals mechanistic diversity among class D carbapenemases. , 2009, Chemistry & biology.
[2] P. Bennett,et al. Common regions e.g. orf513 and antibiotic resistance: IS91-like elements evolving complex class 1 integrons. , 2006, The Journal of antimicrobial chemotherapy.
[3] P. Nordmann,et al. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. , 2009, The Lancet. Infectious diseases.
[4] C. Tribuddharat,et al. Integron-Mediated Rifampin Resistance inPseudomonas aeruginosa , 1999, Antimicrobial Agents and Chemotherapy.
[5] Thierry Naas,et al. Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-β-Lactamase and Its Plasmid- and Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in France , 2000, Antimicrobial Agents and Chemotherapy.
[6] A. Clarke,et al. Novel mechanism of hydrolysis of therapeutic beta-lactams by Stenotrophomonas maltophilia L1 metallo-beta-lactamase. , 2001, The Journal of biological chemistry.
[7] P. Nordmann,et al. Carbapenemases: molecular diversity and clinical consequences. , 2007, Future microbiology.
[8] A. Karabinis,et al. VIM-1-producing Klebsiella pneumoniae bloodstream infections: analysis of 28 cases. , 2007, International journal of antimicrobial agents.
[9] C. Zeana,et al. Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan. , 2006, American journal of infection control.
[10] P. Nordmann,et al. VIM-5 metallo-beta-lactamase-producing Pseudomonas putida from Turkey. , 2009, International journal of antimicrobial agents.
[11] T. Walsh. Clinically significant carbapenemases: an update , 2008, Current opinion in infectious diseases.
[12] M. Toleman,et al. Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland, 1998-2006. , 2008, The Journal of antimicrobial chemotherapy.
[13] J. Campos,et al. Characterization of plasmids encoding blaESBL and surrounding genes in Spanish clinical isolates of Escherichia coli and Klebsiella pneumoniae. , 2008, The Journal of antimicrobial chemotherapy.
[14] J. Herrmann,et al. Plasmid-Mediated Rifampin Resistance Encoded by anarr-2-Like Gene Cassette in Klebsiella pneumoniae Producing an ACC-1 Class C β-Lactamase , 2001, Antimicrobial Agents and Chemotherapy.
[15] Ronald N. Jones,et al. bla VIM-7, an Evolutionarily Distinct Metallo-β-Lactamase Gene in a Pseudomonas aeruginosa Isolate from the United States , 2004, Antimicrobial Agents and Chemotherapy.
[16] Ronald N. Jones,et al. Biochemical Characterization of the Acquired Metallo-β-Lactamase SPM-1 from Pseudomonas aeruginosa , 2003, Antimicrobial Agents and Chemotherapy.
[17] A. Vatopoulos. High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece--a review of the current evidence. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[18] Sylvain Brisse,et al. Multilocus Sequence Typing of Klebsiella pneumoniae Nosocomial Isolates , 2005, Journal of Clinical Microbiology.
[19] P. Nordmann,et al. Molecular Epidemiology of the Integron-Located VEB-1 Extended-Spectrum β-Lactamase in Nosocomial Enterobacterial Isolates in Bangkok, Thailand , 2001, Journal of Clinical Microbiology.
[20] David L Paterson. Resistance in gram-negative bacteria: enterobacteriaceae. , 2006, The American journal of medicine.
[21] M. Roberts. Resistance to macrolide, lincosamide, streptogramin, ketolide, and oxazolidinone antibiotics , 2004, Molecular biotechnology.
[22] A. Brisabois,et al. Novel Plasmid-Encoded Ceftazidime-Hydrolyzing CTX-M-53 Extended-Spectrum β-Lactamase from Salmonella enterica Serotypes Westhampton and Senftenberg , 2009, Antimicrobial Agents and Chemotherapy.
[23] M. Toleman,et al. Evolution of the IS CR 3 Group of IS CR Elements , 2008 .
[24] Amersham Pharmacia Biotech. Plasmid-Mediated Rifampin Resistance Encoded by an arr-2-Like Gene Cassette in Klebsiella pneumoniae Producing an ACC-1 Class C -Lactamase , 2001 .
[25] K. Bush,et al. Carbapenemases: the Versatile β-Lactamases , 2007, Clinical Microbiology Reviews.
[26] T. Kirikae,et al. KHM-1, a Novel Plasmid-Mediated Metallo-β-Lactamase from a Citrobacter freundii Clinical Isolate , 2008, Antimicrobial Agents and Chemotherapy.
[27] P. Bennett,et al. ISCR Elements: Novel Gene-Capturing Systems of the 21st Century? , 2006, Microbiology and Molecular Biology Reviews.
[28] M. Toleman,et al. Evolution of the ISCR3 Group of ISCR Elements , 2008, Antimicrobial Agents and Chemotherapy.
[29] M. Roberts,et al. Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes. , 2008, FEMS microbiology letters.
[30] J. Jorgensen,et al. KPC-2-Producing Enterobacter cloacae and Pseudomonas putida Coinfection in a Liver Transplant Recipient , 2008, Antimicrobial Agents and Chemotherapy.
[31] Jane W. Marsh,et al. Integron-mediated Multidrug Resistance in a Global Collection of Nontyphoidal Salmonella enterica Isolates , 2009, Emerging infectious diseases.
[32] P. Nordmann,et al. Plasmid-Encoded Carbapenem-Hydrolyzing β-Lactamase OXA-48 in an Imipenem-Susceptible Klebsiella pneumoniae Strain from Belgium , 2008, Antimicrobial Agents and Chemotherapy.
[33] Thomas E. Besser,et al. Variability in the Region Downstream of the blaCMY-2 β-Lactamase Gene in Escherichia coli and Salmonella enterica Plasmids , 2006, Antimicrobial Agents and Chemotherapy.
[34] Moreno Galleni,et al. Standard Numbering Scheme for Class B β-Lactamases , 2001, Antimicrobial Agents and Chemotherapy.
[35] A. Sundsfjord,et al. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden. , 2009, The Journal of antimicrobial chemotherapy.
[36] Ronald N. Jones,et al. Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. , 2002, The Journal of antimicrobial chemotherapy.
[37] D. S. Hammond,et al. Selection of SHV Extended-Spectrum-β-Lactamase-Dependent Cefotaxime and Ceftazidime Resistance in Klebsiella pneumoniae Requires a Plasmid-Borne blaSHV Gene , 2007, Antimicrobial Agents and Chemotherapy.
[38] M. Castanheira,et al. Kinetic Characterization of VIM-7, a Divergent Member of the VIM Metallo-β-Lactamase Family , 2008, Antimicrobial Agents and Chemotherapy.
[39] Timothy R. Walsh,et al. Metallo-β-Lactamases: the Quiet before the Storm? , 2005, Clinical Microbiology Reviews.
[40] A. Clarke,et al. Novel Mechanism of Hydrolysis of Therapeutic β-Lactams byStenotrophomonas maltophilia L1 Metallo-β-lactamase* , 2001, The Journal of Biological Chemistry.
[41] P. Nordmann,et al. Spread of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in Istanbul, Turkey , 2008, Antimicrobial Agents and Chemotherapy.
[42] Alejandro J. Vila,et al. Metallo-β-lactamases: Novel Weaponry for Antibiotic Resistance in Bacteria , 2006 .
[43] F. Weill,et al. Association of IS26-composite transposons and complex In4-type integrons generates novel multidrug resistance loci in Salmonella genomic island 1. , 2008, The Journal of antimicrobial chemotherapy.
[44] O. Dideberg,et al. The three-dimensional structure of VIM-2, a Zn-beta-lactamase from Pseudomonas aeruginosa in its reduced and oxidised form. , 2008, Journal of molecular biology.